Across TCGA pan-cancer cohorts, LINC01588 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC01588 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher LINC01588 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01588 expression acts as an unfavorable survival marker.

THYM and SKCM are the cancer types where LINC01588 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
SKCM	OS	Median	All	0.230	0.783	.002	30	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01588 tumor-vs-normal RNA expression · all LINC01588 data types